Oral spray solution
3 x 10ml
THC/CBD is indicated as treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically signiﬁcant improvement in spasticity related symptoms during an initial trial of therapy.
Physicians throughout EU are prescribing THC/CBD oral spray solution as an initial treatment to determine patient tolerance, and for a number of off label causes ranging from pain, to sleep, stressrelief and concentration.
VERDUO is a generic THC/CBD-format - for oral ingestion.
Did you know?
THC is potentially aversive to people suffering from psychotic states or is diagnosed with mental illness.
THC is potentially addictive for sensitive patients.
THC interacts with Warfarin.
Do not use cannabinoid products without first consulting your physician.
Cannabinoids derived from the flower of the Cannabis Sativa Sativa (L.) has been found to have therapeutic medical use and is showing great potential for treating diseases or conditions. The cannabis plant contains more than 100 different chemicals known as cannabinoids; each one has a varying effect.
Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two cannabinoids that have been researched the most.
THC & CBD are typically the two cannabinoids that administered within medications.
Today research is being conducted all around the world to see if cannabis-based medicines could be used for clinical treatments of an array of diseases such as: